136 related articles for article (PubMed ID: 11146549)
1. Ductal growth is impeded in mammary glands of C-neu transgenic mice.
Mukherjee S; Louie SG; Campbell M; Esserman L; Shyamala G
Oncogene; 2000 Dec; 19(52):5982-7. PubMed ID: 11146549
[TBL] [Abstract][Full Text] [Related]
2. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Shyamala G; Chou YC; Cardiff RD; Vargis E
Cancer Res; 2006 Nov; 66(21):10391-8. PubMed ID: 17079459
[TBL] [Abstract][Full Text] [Related]
3. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth.
Andrechek ER; White D; Muller WJ
Oncogene; 2005 Jan; 24(5):932-7. PubMed ID: 15580295
[TBL] [Abstract][Full Text] [Related]
5. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; BisarĂ² B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
6. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD
Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
[TBL] [Abstract][Full Text] [Related]
8. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
9. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis.
Sebastian J; Richards RG; Walker MP; Wiesen JF; Werb Z; Derynck R; Hom YK; Cunha GR; DiAugustine RP
Cell Growth Differ; 1998 Sep; 9(9):777-85. PubMed ID: 9751121
[TBL] [Abstract][Full Text] [Related]
10. TGF beta regulation of cell proliferation.
Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland.
Hovey RC; Trott JF; Ginsburg E; Goldhar A; Sasaki MM; Fountain SJ; Sundararajan K; Vonderhaar BK
Dev Dyn; 2001 Oct; 222(2):192-205. PubMed ID: 11668597
[TBL] [Abstract][Full Text] [Related]
12. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
[TBL] [Abstract][Full Text] [Related]
13. Estrogen dependent regulation of estrogen receptor gene expression in normal mammary gland and its relationship to estrogenic sensitivity.
Shyamala G; Schneider W; Guiot MC
Receptor; 1992; 2(2):121-8. PubMed ID: 1472945
[TBL] [Abstract][Full Text] [Related]
14. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation.
Jones FE; Stern DF
Oncogene; 1999 Jun; 18(23):3481-90. PubMed ID: 10376526
[TBL] [Abstract][Full Text] [Related]
15. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
16. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using reconstituted epithelium.
Edwards PA
Biochem Soc Symp; 1998; 63():21-34. PubMed ID: 9513708
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
19. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
20. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]